Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease

NCT01973543 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Neurocrine Biosciences

Collaborators